Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,145 total articles

Analyst Favors Coca-Cola HBC and Royal Unibrew in European Non-Alcoholic Drinks, Citing Growth and Turnaround Potential

Analyst Favors Coca-Cola HBC and Royal Unibrew in European Non-Alcoholic Drinks, Citing Growth and Turnaround Potential

Bernstein identifies two top picks within the European non-alcoholic beverages space: Coca-Cola HBC (CCH), favored for its growth trajectory and margin improvement potential, and Royal Unibrew (RBREW), viewed as a high-upside turnaround candidate after recent share weakness. The broker points to revenue momentum, operational leverage and brand mix …

Insider Moves: Large Purchases at Prelude, Major Dispositions at NuScale Lead Thursday Filings

Insider Moves: Large Purchases at Prelude, Major Dispositions at NuScale Lead Thursday Filings

Insider filings disclosed Thursday reveal sizeable purchases in Prelude Therapeutics and Bank First Corp alongside notable executive and institutional sales at NuScale Power, CoreWeave, Arista Networks, Everpure and SBC Medical Group. The filings detail transaction sizes, prices, and the mechanics behind several trades - including underwritten offe…

Lakewood-Amedex Shares Jump 20% After Nasdaq Direct Listing

Lakewood-Amedex Shares Jump 20% After Nasdaq Direct Listing

Lakewood-Amedex Biotherapeutics saw its stock climb 20% when it began trading on the Nasdaq Capital Market under the ticker LABT. The clinical-stage company, advancing the Bisphosphocin class of antimicrobials and lead topical candidate Nu-3 for infected diabetic foot ulcers, plans an initial Phase 2a safety and dose-response study followed by a pl…

Eli Lilly Shares Retreat as GLP-1 Script Growth Shows Mixed Signals

Eli Lilly Shares Retreat as GLP-1 Script Growth Shows Mixed Signals

Eli Lilly stock slid about 2% after weekly prescription figures displayed mixed trends within the company's GLP-1 lineup. Mounjaro posted a slight increase in both total and new prescriptions week-over-week, while Zepbound edged lower in total scripts but rose in new prescriptions. The broader GLP-1 category expanded roughly 32% year-over-year. Fou…

UBS Says Macro Setup Should Support Further Gains in Global Stocks

UBS Says Macro Setup Should Support Further Gains in Global Stocks

UBS holds an optimistic stance on global equities, pointing to a constructive macro environment, expected Fed rate easing, easing tariff headwinds, supportive fiscal measures and a manufacturing recovery as foundations for broad-based earnings growth. The firm projects 12% EPS growth for the MSCI AC World Index this year and highlights sector and r…